399 related articles for article (PubMed ID: 2971724)
1. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.
Donato NJ; Rotbein J; Rosenblum MG
J Cell Biochem; 1991 May; 46(1):69-77. PubMed ID: 1874802
[TBL] [Abstract][Full Text] [Related]
3. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
5. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial cell proliferation: regulation of cellular polyamines.
Morrison RF; Seidel ER
Cardiovasc Res; 1995 Jun; 29(6):841-7. PubMed ID: 7656288
[TBL] [Abstract][Full Text] [Related]
7. Role of polyamines in estradiol-induced growth of human breast cancer cells.
Lima G; Shiu RP
Cancer Res; 1985 Jun; 45(6):2466-70. PubMed ID: 3921243
[TBL] [Abstract][Full Text] [Related]
8. Role of putrescine in interleukin 1 beta production in human histiocytic lymphoma cell line U937.
Tahara H; Otani S; Matsui-Yuasa I; Koyama H; Nishizawa Y; Morisawa S; Morii H
J Cell Physiol; 1991 May; 147(2):199-207. PubMed ID: 2040654
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ornithine decarboxylase activity and cell growth by diamines: a comparison between the effects of two homologs, 1,3-diaminopropane and 1,4-diaminobutane (putrescine).
Linden M; Oredsson SM; Anehus S; Heby O
J Cell Biochem; 1985; 29(2):105-13. PubMed ID: 3934184
[TBL] [Abstract][Full Text] [Related]
11. Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture.
Glikman P; Manni A; Demers L; Bartholomew M
Cancer Res; 1989 Mar; 49(6):1371-6. PubMed ID: 2493979
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
[TBL] [Abstract][Full Text] [Related]
13. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
Ghoda L; Basu HS; Porter CW; Marton LJ; Coffino P
Mol Pharmacol; 1992 Aug; 42(2):302-6. PubMed ID: 1513327
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of in vitro antitumor effects of interleukin 1 (IL 1).
Endo Y; Matsushima K; Oppenheim JJ
Immunobiology; 1986 Sep; 172(3-5):316-22. PubMed ID: 3492432
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
17. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
Bowlin TL; Hoeper BJ; Rosenberger AL; Davis GF; Sunkara PS
Cancer Res; 1990 Aug; 50(15):4510-4. PubMed ID: 2114941
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
19. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.
Takigawa M; Enomoto M; Nishida Y; Pan HO; Kinoshita A; Suzuki F
Cancer Res; 1990 Jul; 50(13):4131-8. PubMed ID: 1693880
[TBL] [Abstract][Full Text] [Related]
20. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]